Neurocrine Biosciences, Inc. (NBIX) Covered Calls

Neurocrine Biosciences, Inc. covered calls Neurocrine Biosciences, Inc. discovers, develops and plans to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders.

You can sell covered calls on Neurocrine Biosciences, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NBIX (prices last updated Tue 4:16 PM ET):

Neurocrine Biosciences, Inc. (NBIX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
145.44 +0.16 141.79 152.78 432K 40 15
Covered Calls For Neurocrine Biosciences, Inc. (NBIX)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 145 8.20 144.58 0.3% 4.4%
Sep 20 145 13.50 139.28 4.1% 24.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company, which discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.